Workflow
Drug Pricing
icon
Search documents
Is Repligen (RGEN) The Best Healthcare Stock to Buy Now?
Yahoo Finance· 2025-10-09 11:46
We recently published Top 10 Stock Recommendations You Can’t Miss Amid Growing AI Bubble Fears. Repligen Corporation (NASDAQ:RGEN) is one of the top recommended stocks. Dan Veru, Palisade Capital Management senior partner and CIO, recently talked about Repligen, a life sciences company involved in the development and production of materials used in the manufacture of biological drugs. Here is why the analyst likes the stock, which is up 10% over the past 12 months. “You need a clearance event. You need s ...
X @Forbes
Forbes· 2025-10-08 04:30
This Startup Hit A $3.25 Billion Valuation Building Software To Fix Drug Pricing https://t.co/a1bmbDi1RS ...
X @Bloomberg
Bloomberg· 2025-10-06 13:22
Amgen joins drugmakers offering discounts to cash-paying patients after Trump’s call to cut prices https://t.co/OtfyomPkAP ...
X @The Economist
The Economist· 2025-10-05 13:00
Rather than seek to import Europe’s prices, the president would be better off borrowing its approach—and establishing an American system of valuing drugs https://t.co/QcTHy2Heka ...
X @The Economist
The Economist· 2025-10-03 10:20
If America shared Europe’s assessment of how to value good health, it might well save money on drugs. But it would come at the cost of worse care than it enjoys today https://t.co/Sw98hBb71f ...
X @The Economist
The Economist· 2025-10-03 06:00
“By raising reimbursements for new drugs while increasing the use of cheaper generic therapies, Europe could spur more investment in lifesaving R&D and defuse Donald Trump’s mutually destructive pricing push,” argues Tomas Philipson in a guest essay https://t.co/Na86UHJlLF ...
X @The Wall Street Journal
Healthcare Industry News - A new drug-buying site called "TrumpRx" has been announced for Americans [1] - The site aims to help Americans save money on prescription drugs [1]
X @Forbes
Forbes· 2025-10-03 03:30
This Startup Hit A $3.25 Billion Valuation Building Software To Fix Drug Pricing https://t.co/a1bmbDi1RS ...
Starting first phase of long-term small cap outperformance relative to large: Palisade's Dan Veru
Youtube· 2025-10-02 18:53
Because your first guest today says that small caps have largely been ignored or unloved for way too long and it's time to think big about the little ones. Dan Vu is here to kick things off. Chief investment officer and senior partner Palisad Capital Management.Dan, great to have you on. You just gave me a stat before the show, which you know, not a lot of things blow my mind, but this did that all Russell 2000, every stock in that index combined is smaller than Nvidia. What do you make of that.>> You know, ...
X @The Economist
The Economist· 2025-10-02 17:15
Rather than seek to import Europe’s prices, the president would be better off borrowing its approach—and establishing an American system of valuing drugs https://t.co/X8quFdo1eN ...